249 related articles for article (PubMed ID: 25188519)
1. Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.
Guo W; Liu R; Bhardwaj G; Yang JC; Changou C; Ma AH; Mazloom A; Chintapalli S; Xiao K; Xiao W; Kumaresan P; Sanchez E; Yeh CT; Evans CP; Patterson R; Lam KS; Kung HJ
Cell Death Dis; 2014 Sep; 5(9):e1409. PubMed ID: 25188519
[TBL] [Abstract][Full Text] [Related]
2. CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.
Guo W; Liu R; Bhardwaj G; Ma AH; Changou C; Yang JC; Li Y; Feng C; Luo Y; Mazloom A; Sanchez E; Wang Y; Huang W; Patterson R; Evans CP; Lam KS; Kung HJ
PLoS One; 2013; 8(8):e70910. PubMed ID: 23967135
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse.
Dai B; Kim O; Xie Y; Guo Z; Xu K; Wang B; Kong X; Melamed J; Chen H; Bieberich CJ; Borowsky AD; Kung HJ; Wei G; Ostrowski MC; Brodie A; Qiu Y
Cancer Res; 2006 Aug; 66(16):8058-64. PubMed ID: 16912182
[TBL] [Abstract][Full Text] [Related]
4. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells.
Qiu Y; Robinson D; Pretlow TG; Kung HJ
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3644-9. PubMed ID: 9520419
[TBL] [Abstract][Full Text] [Related]
5. Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.
Dai B; Chen H; Guo S; Yang X; Linn DE; Sun F; Li W; Guo Z; Xu K; Kim O; Kong X; Melamed J; Qiu S; Chen H; Qiu Y
Cancer Res; 2010 Jul; 70(13):5587-96. PubMed ID: 20570899
[TBL] [Abstract][Full Text] [Related]
6. Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.
Wang JD; Chen XY; Ji KW; Tao F
Am J Transl Res; 2016; 8(7):3003-12. PubMed ID: 27508020
[TBL] [Abstract][Full Text] [Related]
7. Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.
Wang X; Wong J; Sevinsky CJ; Kokabee L; Khan F; Sun Y; Conklin DS
Mol Cancer Ther; 2016 Sep; 15(9):2198-208. PubMed ID: 27256378
[TBL] [Abstract][Full Text] [Related]
8. Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ΞΆ, regulates shuttling, and attenuates both tonic and induced signaling in B cells.
Mohammad DK; Nore BF; Hussain A; Gustafsson MO; Mohamed AJ; Smith CI
Mol Cell Biol; 2013 Aug; 33(16):3214-26. PubMed ID: 23754751
[TBL] [Abstract][Full Text] [Related]
9. Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation.
Tsai YT; Su YH; Fang SS; Huang TN; Qiu Y; Jou YS; Shih HM; Kung HJ; Chen RH
Mol Cell Biol; 2000 Mar; 20(6):2043-54. PubMed ID: 10688651
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer.
Kokabee L; Wang X; Sevinsky CJ; Wang WL; Cheu L; Chittur SV; Karimipoor M; Tenniswood M; Conklin DS
Cancer Biol Ther; 2015; 16(11):1604-15. PubMed ID: 26383180
[TBL] [Abstract][Full Text] [Related]
12. MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer.
Qi W; Cooke LS; Stejskal A; Riley C; Croce KD; Saldanha JW; Bearss D; Mahadevan D
BMC Cancer; 2009 May; 9():142. PubMed ID: 19432987
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.
Sakai I; Miyake H; Terakawa T; Fujisawa M
Cancer Sci; 2011 Apr; 102(4):769-75. PubMed ID: 21214673
[TBL] [Abstract][Full Text] [Related]
14. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin.
Xue LY; Qiu Y; He J; Kung HJ; Oleinick NL
Oncogene; 1999 Jun; 18(22):3391-8. PubMed ID: 10362360
[TBL] [Abstract][Full Text] [Related]
15. Protein-tyrosine phosphatase D1, a potential regulator and effector for Tec family kinases.
Jui HY; Tseng RJ; Wen X; Fang HI; Huang LM; Chen KY; Kung HJ; Ann DK; Shih HM
J Biol Chem; 2000 Dec; 275(52):41124-32. PubMed ID: 11013262
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.
Nomura T; Yamasaki M; Hirai K; Inoue T; Sato R; Matsuura K; Moriyama M; Sato F; Mimata H
Mol Cancer; 2013 Apr; 12():27. PubMed ID: 23566222
[TBL] [Abstract][Full Text] [Related]
17. Functional roles of Src and Fgr in ovarian carcinoma.
Kim HS; Han HD; Armaiz-Pena GN; Stone RL; Nam EJ; Lee JW; Shahzad MM; Nick AM; Lee SJ; Roh JW; Nishimura M; Mangala LS; Bottsford-Miller J; Gallick GE; Lopez-Berestein G; Sood AK
Clin Cancer Res; 2011 Apr; 17(7):1713-21. PubMed ID: 21300758
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Etk/Bmx protects against ischemic brain injury.
Chen KY; Wu CC; Chang CF; Chen YH; Chiu WT; Lou YH; Chen YH; Shih HM; Chiang YH
Cell Transplant; 2012; 21(1):345-54. PubMed ID: 21929872
[TBL] [Abstract][Full Text] [Related]
19. The expression and role of tyrosine kinase ETK/BMX in renal cell carcinoma.
Zhuang J; Tu X; Cao K; Guo S; Mao X; Pan J; Huang B; Chen X; Gao Y; Qiu S
J Exp Clin Cancer Res; 2014 Mar; 33(1):25. PubMed ID: 24606948
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic activation of ETK/Bmx tyrosine kinase by caspases.
Wu YM; Huang CL; Kung HJ; Huang CY
J Biol Chem; 2001 May; 276(21):17672-8. PubMed ID: 11278797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
